ALT5 Sigma Corp (ALTS) - Dilution Analysis

10-Q filing | 126.8M shares outstanding

8-K filing: ALT5 Sigma Corporation issued 12,670,257 shares of common stock and granted warrants to purchase up to 32,731,496 additional shares of common stock to the four owners of Block Street Corp. as part of a Stock Exchange Agreement. ($12.0M proceeds)

10-Q filing | 126.2M shares outstanding

8-K filing: ALT5 Sigma Corporation settled litigation, issuing shares of common stock to Wellington Peel, LLC and a former employee as part of the settlement.

8-K filing: ALT5 Sigma Corporation completed a registered direct offering of 100,000,000 shares of common stock at $7.50 per share and a private placement of 1,000,000 shares of common stock at $7.50 per share, pre-funded warrants to purchase 99,000,000 shares, and warrants to purchase 20,000,000 shares. ($750.0M proceeds)

10-Q filing | 122.6M shares outstanding

8-K filing: ALT5 Sigma Corporation entered into a registered direct offering and a private placement offering, issuing shares of common stock and pre-funded warrants. They also amended the Certificates of Designation for its Series B Preferred Stock, Series Q Convertible Preferred Stock, and Series I Convertible Preferred Stock to provide voting rights for the holders of the Preferred Stock. ($750.0M proceeds)

S-3/A filing: ALT5 Sigma Corporation files an S-3/A to register the offer and sale of common stock, preferred stock, debt securities, warrants, rights, and units, with a maximum aggregate offering price of $2,000,000,000.

8-K filing: ALT5 Sigma Corporation acquired Mswipe through a purchase agreement involving the issuance of restricted common stock, warrants, shares in Alyea Therapeutics Corporation, and promissory notes. ($6.1M proceeds)

10-Q filing | 17.5M shares outstanding

10-K filing | 16.1M shares outstanding

10-Q filing | 12.8M shares outstanding

8-K filing: Alt5 Sigma Corporation entered into Unit Purchase Agreements with three investors, involving the issuance of non-convertible debentures and warrants to purchase common stock, with the initial tranche of warrants required to be exercised within 15 days of the Original Issue Date.

10-Q filing | 12.8M shares outstanding

8-K filing: JanOne Inc. acquired Alt 5 Sigma, Inc. through a merger, issuing approximately 1,799,100 shares of common stock, 34,207 shares of Series B Preferred Stock, and 3,200 shares of Series M Preferred Stock to Alt 5's legacy equity holders and finders. ($7.45M proceeds)

8-K filing: JanOne Inc. entered into a Securities Purchase Agreement for the sale of 79,782 units, each consisting of one share of common stock and one warrant, at a price of $3.775 per unit in a registered direct offering. ($0.3M proceeds)

10-Q filing | 9.0M shares outstanding

S-3 filing: JanOne files an S-3 form to register the offering of common stock, preferred stock, debt securities, warrants, rights and units with an aggregate offering price of up to $100,000,000.

10-K filing | 8.6M shares outstanding

8-K filing: JanOne Inc. completed a sale of units to two investors, with each unit consisting of one share of common stock and one warrant, at a price of $0.735 per unit, resulting in gross proceeds of $600,000. ($0.6M proceeds)

8-K filing: JanOne Inc. entered into a Warrant Purchase Agreement with an institutional investor to purchase a Common Stock Purchase Warrant for an aggregate price of $250,000. ($0.25M proceeds)

10-Q filing | 5.0M shares outstanding

8-K filing: JanOne Inc. completed a registered direct offering and a concurrent private placement on August 22, 2023, selling shares of common stock and pre-funded warrants to an institutional investor, and warrants in a private placement. ($0.79M proceeds)

10-Q filing | 3.7M shares outstanding

10-Q filing | 3.6M shares outstanding

10-K filing | 3.6M shares outstanding

8-K filing: JanOne Inc. completed a registered direct offering of 361,000 shares of common stock at $1.17 per share, resulting in gross proceeds of approximately $422,000. ($0.42M proceeds)

8-K filing: JanOne acquired Soin Therapeutics LLC and issued 100,000 shares of Series S Convertible Preferred Stock to Dr. Soin, the sole stockholder of STLLC, in an all-stock transaction valued at $13,000,000, potentially increasing to $30,000,000 based on revenue. ($13.0M proceeds)

10-Q filing | 3.2M shares outstanding

10-Q filing | 3.2M shares outstanding

8-K filing: JanOne Inc. sold substantially all assets of its subsidiary GeoTraq Inc. to SPYR Technologies Inc. for $13.5 million, consisting of cash and 30,000,000 shares of SPYR's common stock and a $12.6 million promissory note.

10-Q filing | 2.8M shares outstanding

10-K filing | 2.7M shares outstanding

10-Q filing | 2.8M shares outstanding

10-Q filing | 2.4M shares outstanding

10-Q filing | 2.8M shares outstanding

10-K filing | 2.4M shares outstanding

8-K filing: JanOne Inc. closed a registered direct offering of 571,428 shares of common stock at $10.50 per share, resulting in gross proceeds of approximately $6,000,000. Following the offering, the Company had 2,401,410 shares of Common Stock outstanding. ($6.0M proceeds)

8-K filing: JanOne Inc. sold 571,428 shares of common stock at $10.50 per share in a registered direct offering, with gross proceeds of approximately $6.0 million, intending to use the net proceeds for general working capital. The offering is expected to close on February 2, 2021. ($6.0M proceeds)

S-3 filing: The filing is for a shelf registration of common stock, preferred stock, and debt securities, warrants, rights, and units, up to an aggregate offering price of $100,000,000.

10-Q filing | 1.9M shares outstanding

S-3 filing: The filing is an S-3 registration statement to register an indeterminate amount of common stock, preferred stock, debt securities, warrants, rights and units up to a proposed aggregate offering price of $100,000,000.

10-Q filing | 2.0M shares outstanding

10-Q filing | 2.0M shares outstanding

10-K filing | 2.0M shares outstanding